Effect of Local Therapy on Survival in Oligometastatic Epidermal Growth Factor Receptor (EGFR) Mutated Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Soon, Y. Y. [1 ]
Lee, C. C. [1 ]
Koh, W. Y. [1 ]
Leong, C. N. [1 ]
Tey, J. [1 ]
机构：
[1] Natl Univ Canc Inst, Radiat Oncol, Singapore, Singapore
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
OLIGOMETASTATIC; EGFR; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P19.04
引用
收藏
页码：S356 / S356
页数：1
相关论文
共 50 条
  • [21] Audit of Epidermal Growth Factor Receptor (EGFR) Mutation Analysis in Non-Small Cell Lung Cancer (NSCLC) in an Irish Cohort
    O'Brien, O.
    Graham, D.
    McCarthy, J.
    Burke, L.
    [J]. JOURNAL OF PATHOLOGY, 2015, 237 : S24 - S24
  • [22] Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations
    Zwitter, Matjaz
    Rajer, Mirjana
    Stanic, Karmen
    Vrankar, Martina
    Doma, Andrej
    Cuderman, Anka
    Grmek, Marko
    Kern, Izidor
    Kovac, Viljem
    [J]. CANCER BIOLOGY & THERAPY, 2016, 17 (08) : 833 - 839
  • [23] Changes in Circulating Epidermal Growth Factor Receptor (EGFR) during Radiotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients
    Ye, Ping
    Zhao, Jing
    Maihle, Nita
    Wang, Shulian
    Jin, Jianyue
    Kong, Feng-Ming
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S605 - S605
  • [24] Population based study of the prevalence of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC)
    Skov, B. G.
    Hogdall, E.
    Clementsen, P.
    Krasnik, M.
    Larsen, K. R.
    Sorensen, J. B.
    Mellemgaard, A.
    [J]. APMIS, 2012, 120 : 14 - 14
  • [25] Epidermal growth factor receptor in non-small cell lung cancer
    Prabhakar, Charles N.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 110 - 118
  • [26] Assessing efficacy and safety of stereotactic body radiation therapy for oligometastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) wild type
    Hu, Xiaolong
    Li, Hongqi
    Liu, Hefei
    Liu, Zhifei
    Xia, Tingyi
    Zhang, Jianchun
    Wang, Yingjie
    [J]. TRANSLATIONAL CANCER RESEARCH, 2021, 10 (01) : 184 - +
  • [27] ERLOTINIB AFTER FAILURE OF GEFITINIB THERAPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) WITH OR WITHOUT EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION
    Saito, Hiroshi
    Kimura, Tomoki
    Abe, Takashi
    Kondo, Masashi
    Ogasawara, Tomohiko
    Tanikawa, Yoshimasa
    Yokoyama, Toshihiko
    Kojima, Eiji
    Yamamoto, Masashi
    Suzuki, Ryujiro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1210 - S1211
  • [28] The role of osimertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer
    Liam, Chong-Kin
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 : S448 - S452
  • [29] Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population
    Aguiar, Filipa
    Fernandes, Gabriela
    Queiroga, Henrique
    Machado, Jose Carlos
    Cirnes, Luis
    Moura, Conceicao Souto
    Hespanhol, Venceslau
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (01): : 10 - 17
  • [30] Mutation of Epidermal Growth Factor Receptor (EGFR) in Patients with Non-Small Cell Lung Cancer (NSCLC) in a University Hospital in Latin America
    Sua, Luz F.
    Rodriguez, Lisa X.
    Fernandez, Liliana
    Munoz, Carlos A.
    Restrepo, Juan G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S591 - S592
12345